Oncogene Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3490 €

Gold OA

-

Green OA

- €

Non OA

Metrics

Oncogene

3,232

SJR Impact factor

329

H Index

545

Total Docs (Last Year)

1782

Total Docs (3 years)

27039

Total Refs

12348

Total Cites (3 years)

1672

Citable Docs (3 years)

7,74

Cites/Doc (2 years)

49,61

Ref/Doc


Best articles

A candidate gene for Drosophila genome methylation

View more

A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31

View more

A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity

View more

A revised and complete map of the chicken c-mil/raf-1 locus

View more

A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit a

View more

a-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and beta-catenin stabilization in cervical cancer

View more

Alpha-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells

View more

Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells

View more

Angiomotin expression promotes hemangioendothelioma invasion

View more

Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria

View more

Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation

View more

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants

View more
SHOW MORE ARTICLES

Chfr inactivation is not associated to chromosomal instability in colon cancers

View more

Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes

View more

Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland

View more

Designer' tumors in mice

View more

Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells

View more

Differentiation induction as a treatment for hematologic malignancies

View more

Disruption of the BLM gene in ATM-null DT40 cells does not exacerbate either phenotype

View more

Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line

View more

Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression

View more

Erratum: Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg

View more

Erratum: Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

View more

Erratum: LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells

View more

Comments

No comments ... Be the first to comment!